Ex vivo evaluation of preoperatively treated rectal cancer specimens of patients undergoing radical resection

Annals of Surgical Oncology
Sebastian G de la FuenteChristopher R Mantyh

Abstract

Previous reports have suggested that a subset of patients with advanced rectal cancer that demonstrate minimal or no residual disease after neoadjuvant treatment may either be followed closely or may undergo local resection. We prospectively evaluated ex vivo local excision specimens of patients undergoing radical resection after preoperative chemoradiation. Patients with newly diagnosed rectal cancer received preoperative chemoradiotherapy followed by total mesorectal excision. Once removed, an ex vivo excision of the tumor bed mimicking a local excision was performed on the back table. Both the ex vivo and mesorectal specimens were inked and assessed. Thirty-seven rectal cancer patients (38% stage II, 62% stage III) were prospectively enrolled onto this study. Tumor downstaging occurred in 35% and nodal status downstaging in 16% of patients. The margins around the primary tumor on all ex vivo local excision specimens were negative. Twenty-nine percent of preoperatively staged stage II cancers either remained at stage II or were upstaged to stage III (21%), while 52% of stage III tumors remained node positive at final pathologic examination. The overall complete response rate was 14%. A significant number of stage II cancers w...Continue Reading

References

Aug 26, 1998·Archives of Surgery·R J HealdJ K MacFarlane
Jan 5, 2002·Annals of Surgical Oncology·M W OnaitisD S Tyler
Feb 19, 2002·Journal of the American College of Surgeons·Spiros P HiotisW Douglas Wong
Dec 23, 2003·The American Journal of Gastroenterology·Arvydas VanagunasSteven J Stryker
Dec 30, 2004·Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract·Angelita Habr-GamaJoaquim Gama-Rodrigues
Mar 16, 2005·Diseases of the Colon and Rectum·Khaled M MadboulyIan C Lavery
Aug 4, 2007·Diseases of the Colon and Rectum·Ron G LandmannMartin R Weiser
Nov 29, 2007·Diseases of the Colon and Rectum·R Glynne-JonesJ Meyrick-Thomas
Jan 19, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·José G GuillemSalvatore Pucciarelli
Jun 3, 2008·Colorectal Disease : the Official Journal of the Association of Coloproctology of Great Britain and Ireland·M BerhoS Wexner
May 1, 2009·Diseases of the Colon and Rectum·Garrett M NashPhilip B Paty
Sep 17, 2009·Journal of the National Comprehensive Cancer Network : JNCCN·Paul F EngstromUNKNOWN National Comprehensive Cancer Network
Oct 17, 2009·Annals of Surgical Oncology·Fabio PacelliGiovanni B Doglietto
Feb 16, 2010·Acta Oncologica·Robert HughesRobert Glynne-Jones
Feb 23, 2010·Diseases of the Colon and Rectum·Emilio D MignanelliDavid W Dietz
Jun 17, 2010·Diseases of the Colon and Rectum·Sanne M E EngelenGeerard L Beets

❮ Previous
Next ❯

Citations

Jul 8, 2015·The Surgeon : Journal of the Royal Colleges of Surgeons of Edinburgh and Ireland·K H ChangJ C Coffey

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.